FDG-PET/CT and SPECT/CT in Oncology
Journal:
Current Medical Imaging
Volume:
4
Page:
63-69
Author(s):
E. Edmund Kim, David J. Yang and Franklin C. Wong
Recent Advances in T Cell Adoptive Immunotherapy of Cancer
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
1-13
Author(s):
Li Zhang and Pouneh Dokouhaki
The Role of Nucleoside Transport in the Antineoplastic Activity of Purine Nucleoside Chemotherapeutic Agents
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
21-30
Author(s):
Carol E. Cass and Karen M. King
Cancer Therapeutics: Emerging Targets and Trends
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
50-56
Author(s):
Mohd. Fahad Ullah
Molecular Replacement in Cancer Therapy: Reversing Cancer Metabolic and Mitochondrial Dysfunction, Fatigue and the Adverse Effects of Cancer Therapy
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
66-76
Author(s):
Garth L. Nicolson and Kenneth A. Conklin
Notch Signaling in Leukemias and Lymphomas
Journal:
Current Molecular Medicine
Volume:
8
Page:
51-59
Author(s):
Franziska Jundt, Rolf Schwarzer and Bernd Dorken
Inducers of Heme Oxygenase-1
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
473-486
Author(s):
M. L. Ferrandiz and I. Devesa
Chemical Origins of Isoform Selectivity in Histone Deacetylase Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
505-528
Author(s):
Alan P. Kozikowski and Kyle V. Butler
From Natural Products to Small Molecule Ketone Histone Deacetylase Inhibitors: Development of New Class Specific Agents
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
545-561
Author(s):
Philip Jones and Christian Steinkuhler
Inhibitors of NAD+ Dependent Histone Deacetylases (Sirtuins)
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
562-573
Author(s):
Manfred Jung, Robert C. Neugebauer and Wolfgang Sippl